SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report
SEC Accession No. 0001193125-11-254283
Filing Date
2011-09-22
Accepted
2011-09-22 15:24:57
Documents
3
Period of Report
2011-09-16
Filing Date Changed
2011-09-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d235169d8k.htm 8-K 21652
2 PRESS RELEASE d235169dex991.htm EX-99.1 8720
3 GRAPHIC g235169ex991_pg01.jpg GRAPHIC 10482
  Complete submission text file 0001193125-11-254283.txt   46248
Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27570 | Film No.: 111103051
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 1